Mechanistically, it has been proposed that VEGF inhibition can upregulate antigen presentation from dendritic cells, decrease proliferation of regulatory T cell, myeloid-derived suppressor cell, and M2-like tumor-associated macrophages, and improve T-cell trafficking and infiltration, all of which contribute to a more favorable tumor microenvironment (18). The gene discussed is VEGFA; the disease is neoplasm.